Clinical Assessment: Acute SOB in CKD + DJ Stent + Recurrent Urosepsis

Clinical Context Summary

1. ADHF (Acute Decompensated Heart Failure)
2. Acute-on-CKD (AKI superimposed on CKD)
3. LRTI / Ongoing Urosepsis with sepsis-related organ dysfunction

Immediate Triage Priorities

• Oxygen saturation, SpO2 -- target >94%
• IV access, cardiac monitoring, 12-lead ECG
• Position upright
• Assess hemodynamic status: BP, HR, capillary refill, JVP
• Foley catheter for urine output monitoring (critical in CKD)

Workup: Parallel Rapid Evaluation

1. Bedside / Clinical Assessment

2. Investigations (Simultaneous)

• CBC - leukocytosis supports infection/sepsis; anaemia worsens dyspnoea
• RFT/electrolytes - serum creatinine, BUN, K+, Na+, HCO3- (compare with baseline); an acute rise in creatinine on CKD = acute-on-CKD
• BNP or NT-proBNP - BNP is ~95-99% sensitive for heart failure but critically CKD falsely elevates BNP/NT-proBNP levels (renal dysfunction reduces clearance). Use age-adjusted NT-proBNP cutoffs for CKD patients; values must be interpreted in clinical context, not in isolation. A very high NT-proBNP still supports ADHF in this patient. - Goldman-Cecil Medicine, p. 471
• Troponin I/T (hs) - most ADHF patients have elevated troponin without active ischaemia; elevation predicts worse outcomes. Also rules in/out ACS as a precipitant.
• Blood cultures x2 (before antibiotics) - for urosepsis workup
• Serum lactate - assess for sepsis-driven hypoperfusion
• LFTs, albumin - hepatic congestion markers, nutritional status
• CRP, Procalcitonin - supports bacterial infection; procalcitonin helps distinguish bacterial from viral LRTI
• ABG - assess oxygenation, ventilation, pH, and metabolic acidosis

• Urine R/M - pyuria, bacteriuria, casts (WBC casts = AKI from pyelonephritis/AIN)
• Urine C&S from catheter specimen (not from around stent)
• Urine albumin:creatinine ratio

• CXR (urgent) - assess for cardiomegaly, pulmonary oedema (Kerley B lines, perihilar haziness, pleural effusion), or consolidation (LRTI). Goldman-Cecil Medicine notes that many patients with acute heart failure show pulmonary venous hypertension and pleural effusions - usually right-sided or bilateral. - Goldman-Cecil Medicine, p. 471
• ECG - rate/rhythm, ischaemia, hypertrophy, arrhythmia (hyperkalemia in CKD = tall tented T waves)
• Point-of-care USS (POCUS) -- if available:
  • Lung: B-lines (>3/zone = pulmonary oedema) vs. A-lines + consolidation (pneumonia)
  • IVC: collapsibility index for volume assessment
  • Cardiac: EF estimation, pericardial effusion, wall motion
  • Renal: hydronephrosis, stent position (DJ stent complication?)
• CT KUB (deferred/non-urgent) - if stent obstruction, migration, or encrustation suspected as a trigger for sepsis flare

Diagnosis-Specific Management

A. If ADHF Confirmed (Volume Overloaded)

• IV Furosemide - start at 1-2.5x the oral daily dose IV (e.g., 40-80 mg IV bolus or infusion). In CKD patients, higher doses are often needed due to reduced tubular secretion. Monitor urine output hourly (target >0.5 mL/kg/hr) and creatinine daily - diuresis may transiently worsen creatinine.
• Caution with aggressive diuresis in a patient who may also be septic (volume-depleted component). Sepsis and heart failure can coexist - the cardiorenal-sepsis triad.
• AVOID ACEi/ARB/ARNI initiation acutely - hold in the setting of AKI-on-CKD. Resume when stable.
• Nitrates (sublingual/IV GTN) if hypertensive, but caution if sepsis with vasodilatory haemodynamics.
• Oxygen - titrate to SpO2; HFNC or NIV (CPAP/BiPAP) if persistent hypoxia or work of breathing increased.
• Recent meta-analysis on diuretics vs. ultrafiltration in ADHF (PMID: 37469222) confirms IV loop diuretics remain first-line; ultrafiltration is reserved for diuretic-refractory cases.

B. If Acute-on-CKD Confirmed

• Volume depletion (sepsis, poor intake)
• Obstruction (DJ stent blocked, encrusted, or malpositioned)
• Nephrotoxin exposure (NSAIDs, contrast, aminoglycosides - AVOID in this patient)
• Haemodynamic insult (septic shock, cardiogenic hypoperfusion)

• Ensure adequate volume resuscitation without overloading (guided by POCUS and clinical response)
• Avoid all nephrotoxins - especially NSAIDs, IV contrast, aminoglycosides
• Potassium monitoring q6-8h - CKD patients at high risk of dangerous hyperkalaemia
• Check DJ stent patency - urology review if obstructed stent is suspected as the septic source
• Nephrology consult early
• If oliguria worsens despite optimisation, consider RRT (HD/CRRT) if renal indications met (AEIOU criteria)

C. If Urosepsis / LRTI Active

• Empiric antibiotics - broad-spectrum, renally dose-adjusted. For urosepsis with DJ stent in situ:
  • IV Piperacillin-tazobactam or Carbapenem (if prior resistant organism or severe sepsis/shock)
  • Add Vancomycin if MRSA risk or healthcare-associated infection
  • Adjust all doses for CKD GFR stage (use renal dosing tables - critical)
• LRTI - if consolidation on CXR: add atypical coverage (Azithromycin or Doxycycline) to beta-lactam. Avoid fluoroquinolones if QT prolonged or renal function severely impaired without dose adjustment.
• Source control - urology must evaluate the DJ stent urgently. An infected, blocked, or encrusted stent is a persistent septic focus and antibiotics alone will not clear it. Stent exchange or removal may be required.
• Sepsis 6 bundle within 1 hour: blood cultures, IV antibiotics, IV fluids (cautious in CKD/ADHF), lactate, urine output monitoring, high-flow O2.

Key Diagnostic Pitfalls in This Case

Monitoring Parameters

• Vitals q1-2h (HR, BP, SpO2, temp, RR)
• Urine output hourly (foley)
• BMP/electrolytes q6-8h initially (K+, creatinine)
• Daily weight
• Daily CXR if on IV diuretics
• Repeat BNP at 24-48h to track treatment response
• Blood cultures results at 48-72h to de-escalate antibiotics

Suggested Consults

• Cardiology - ADHF management, echo, possible ICD/CRT evaluation if structural disease
• Nephrology - AKI-on-CKD, RRT planning, dose adjustments
• Urology - urgent DJ stent assessment (source control)
• Pulmonology/ID - if LRTI with resistant organism or atypical presentation

Summary Framework

Acute SOB in CKD + DJ stent + urosepsis
             |
     ________|_________
    |         |        |
  ADHF     AoC-CKD   LRTI/Sepsis
    |         |        |
 Diurese   Remove     Abx +
 cautiously nephrotoxins Stent review
    |         |        |
         Integrated management
         (POCUS-guided fluid balance,
          renally-dosed drugs,
          urology source control,
          ECG/K+ monitoring)